The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dog Vaccines Market Research Report 2025
Synopsis
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
The global Dog Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dog Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dog Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dog Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dog Vaccines.
Report Scope
The Dog Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dog Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dog Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Below 6 Months
Above Months
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dog Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
The global Dog Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dog Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dog Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dog Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dog Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dog Vaccines.
Report Scope
The Dog Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dog Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dog Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Below 6 Months
Above Months
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dog Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dog Vaccines Market Overview
1.1 Product Overview and Scope of Dog Vaccines
1.2 Dog Vaccines Segment by Type
1.2.1 Global Dog Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Dog Vaccines Segment by Application
1.3.1 Global Dog Vaccines Market Value by Application: (2024-2030)
1.3.2 Below 6 Months
1.3.3 Above Months
1.4 Global Dog Vaccines Market Size Estimates and Forecasts
1.4.1 Global Dog Vaccines Revenue 2019-2030
1.4.2 Global Dog Vaccines Sales 2019-2030
1.4.3 Global Dog Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dog Vaccines Market Competition by Manufacturers
2.1 Global Dog Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dog Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dog Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Dog Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dog Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dog Vaccines, Product Type & Application
2.7 Dog Vaccines Market Competitive Situation and Trends
2.7.1 Dog Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dog Vaccines Players Market Share by Revenue
2.7.3 Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dog Vaccines Retrospective Market Scenario by Region
3.1 Global Dog Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dog Vaccines Global Dog Vaccines Sales by Region: 2019-2030
3.2.1 Global Dog Vaccines Sales by Region: 2019-2024
3.2.2 Global Dog Vaccines Sales by Region: 2025-2030
3.3 Global Dog Vaccines Global Dog Vaccines Revenue by Region: 2019-2030
3.3.1 Global Dog Vaccines Revenue by Region: 2019-2024
3.3.2 Global Dog Vaccines Revenue by Region: 2025-2030
3.4 North America Dog Vaccines Market Facts & Figures by Country
3.4.1 North America Dog Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dog Vaccines Sales by Country (2019-2030)
3.4.3 North America Dog Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dog Vaccines Market Facts & Figures by Country
3.5.1 Europe Dog Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dog Vaccines Sales by Country (2019-2030)
3.5.3 Europe Dog Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dog Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Dog Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dog Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Dog Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dog Vaccines Market Facts & Figures by Country
3.7.1 Latin America Dog Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dog Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Dog Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dog Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Dog Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dog Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dog Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dog Vaccines Sales by Type (2019-2030)
4.1.1 Global Dog Vaccines Sales by Type (2019-2024)
4.1.2 Global Dog Vaccines Sales by Type (2025-2030)
4.1.3 Global Dog Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Dog Vaccines Revenue by Type (2019-2030)
4.2.1 Global Dog Vaccines Revenue by Type (2019-2024)
4.2.2 Global Dog Vaccines Revenue by Type (2025-2030)
4.2.3 Global Dog Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Dog Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dog Vaccines Sales by Application (2019-2030)
5.1.1 Global Dog Vaccines Sales by Application (2019-2024)
5.1.2 Global Dog Vaccines Sales by Application (2025-2030)
5.1.3 Global Dog Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Dog Vaccines Revenue by Application (2019-2030)
5.2.1 Global Dog Vaccines Revenue by Application (2019-2024)
5.2.2 Global Dog Vaccines Revenue by Application (2025-2030)
5.2.3 Global Dog Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Dog Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare Dog Vaccines Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Vetoquinol S.A
6.2.1 Vetoquinol S.A Corporation Information
6.2.2 Vetoquinol S.A Description and Business Overview
6.2.3 Vetoquinol S.A Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vetoquinol S.A Dog Vaccines Product Portfolio
6.2.5 Vetoquinol S.A Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Dog Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Dog Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly Dog Vaccines Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Heska Co.
6.6.1 Heska Co. Corporation Information
6.6.2 Heska Co. Description and Business Overview
6.6.3 Heska Co. Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heska Co. Dog Vaccines Product Portfolio
6.6.5 Heska Co. Recent Developments/Updates
6.7 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Animal Health Dog Vaccines Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 Merial (Sanofi)
6.8.1 Merial (Sanofi) Corporation Information
6.8.2 Merial (Sanofi) Description and Business Overview
6.8.3 Merial (Sanofi) Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merial (Sanofi) Dog Vaccines Product Portfolio
6.8.5 Merial (Sanofi) Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Corporation Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Virbac Dog Vaccines Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Zoetis (Pfizer)
6.10.1 Zoetis (Pfizer) Corporation Information
6.10.2 Zoetis (Pfizer) Description and Business Overview
6.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zoetis (Pfizer) Dog Vaccines Product Portfolio
6.10.5 Zoetis (Pfizer) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dog Vaccines Industry Chain Analysis
7.2 Dog Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dog Vaccines Production Mode & Process
7.4 Dog Vaccines Sales and Marketing
7.4.1 Dog Vaccines Sales Channels
7.4.2 Dog Vaccines Distributors
7.5 Dog Vaccines Customers
8 Dog Vaccines Market Dynamics
8.1 Dog Vaccines Industry Trends
8.2 Dog Vaccines Market Drivers
8.3 Dog Vaccines Market Challenges
8.4 Dog Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
